Antioxidant and hepatoprotective effects of naringenin and its β-cyclodextrin formulation in mice intoxicated with carbon tetrachloride: A comparative study

Journal of Medicinal Food

Volumn 17, Issue 6, 2014, Pages 670-677

  Hermenean, Anca ^a   Ardelean, Aurel ^a   Stan, Miruna ^b   Hadaruga, Nicoleta ^c   Mihali, Ciprian Valentin ^a   Costache, Marieta ^b   Dinischiotu, Anca ^b  

^a VASILE GOLDIS WESTERN UNIVERSITY OF ARAD   (Romania)

^b UNIVERSITY OF BUCHAREST   (Romania)

^c BANAT S UNIVERSITY OF AGRICULTURAL SCIENCES AND VETERINARY MEDICINE   (Romania)

Author keywords

Antioxidant activity; CCl4; Hepatoprotection; Naringenin

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETA CYCLODEXTRIN; CARBON TETRACHLORIDE; FLAVONOID; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NARINGENIN; SUPEROXIDE DISMUTASE; ANTIOXIDANT; BETA CYCLODEXTRIN DERIVATIVE; FLAVANONE DERIVATIVE; PLANT EXTRACT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG INTOXICATION; ELECTRON MICROSCOPY; ENZYME ACTIVITY; HISTOPATHOLOGY; LIPID PEROXIDATION ASSAY; LIVER CELL; LIVER FIBROSIS; LIVER NECROSIS; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CACAO; CARBON TETRACHLORIDE POISONING; CHEMISTRY; CITRUS; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; LIPID PEROXIDATION; LIVER; METABOLISM; PATHOLOGY; PHYTOTHERAPY; TOMATO; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BETA-CYCLODEXTRINS; CACAO; CARBON TETRACHLORIDE POISONING; CITRUS; DRUG DELIVERY SYSTEMS; DRUG-INDUCED LIVER INJURY; FLAVANONES; LIPID PEROXIDATION; LIVER; LYCOPERSICON ESCULENTUM; MALE; PHYTOTHERAPY; PLANT EXTRACTS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

EID: 84902505227     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2013.0007     Document Type: Article

References (52)

1. Gill RQ, Sterling RK: Acute liver failure. J Clin Gastroenterol 2001;33:191-198. (Pubitemid 32762887)
2. Tanikawa K, Torimura T: Studies on oxidative stress in liver diseases: Important future trends in liver research. Med Mol Morphol 2006;39:22-27
3. Videla LA: Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms. World J Hepatol 2009;1: 72-78
4. Nijveldt RJ, van Nood E, van Hoorn DEC, Boelens PG, van Norren K, van Leeuwen PAM: Flavonoids: A review of probable mechanisms of action and potential applications. Am J Clin Nutr 2001;74:418-425. (Pubitemid 32880250)
5. Renugadevi J, Prabu SM: Cadmium-induced hepatotoxicity in rats and the protective effect of naringenin. Exp Toxicol Pathol 2010;62:171-181
6. Prabu SM, Shagirtha K, Renugadevi J: Naringenin in combination with vitamin C and E potentially protects oxidative stress- mediated hepatic injury in cadmium-intoxicated rats. J Nutr Sci Vitaminol 2011;57:177-185
7. Jain A, Yadav A, Bozhkov AI, Padalko VI, Flora SJS: Therapeutic efficacy of silymarin and naringenin in reducing arsenic- induced hepatic damage in young rats. Ecotoxicol Environ Safe 2011;77:607-614
8. Wang J, Yang Z, Lin L, Zhao Z, Liu Z, Liu X: Protective effect of naringenin against lead-induced oxidative stress in rats. Biol Trace Elem Res 2012;146:354-359
9. Lee MH, Yoon S, Moon JO: The flavonoid naringenin inhibits dimethylnitrosamine-induced liver damage in rats. Biol Pharm Bull 2004;27:72-76. (Pubitemid 41656676)
10. Pari L, Gnansoundari M: Influence of naringenin on oxytetracycline mediated oxidative damage in rat liver. Basic Clin Pharmacol 2006;98:456-461
11. Leonardy T, Vanamala J, Taddeo S, Davidson LA, Murphy ME, Patil BS, Wang N, Carroll RJ, Chapkin RS, Lupton JR, Turner ND: Apigenin and naringenin suppress colon carcinogenesis through the aberrant crypt stage in azoxymethane-treated rats. Exp Biol Med 2010;235:710-717
12. Sabarinathan D, Mahalakshmi P, Vanisree AJ: Naringenin promote apoptosis in cerebrally implanted C6 glioma cells. Mol Cell Biochem 2010;345:215-222
13. Qin L, Jin L, Lu L, Lu X, Zhang C, Zhang F, Liang W: Naringenin reduces lung metastasis in a breast cancer resection model. Protein Cell 2011;2:507-516
14. Soromou LW, Zhang Z, Li R, Chen N, Guo W, Huo M, Guan S, Lu J, Deng X: Regulation of inflammatory cytokines in lipopolysaccharide- stimulated RAW 264.7 murine macrophage by 7- 0- methyl-naringenin. Molecules 2012;17:3574-3585
15. Ribeiro IA, Rocha J, Sepodes B, Mota-Filipe H, Ribeiro MH: Effects of naringenin enzymatic hydrolysis towards naringenin on the anti-inflamatory activity of both compounds. J Mol Catal B Enzym 2008;52-53:13-18
16. Bodet C, La VD, Epifano F, Grenier D: Naringenin has antiinflammatory properties in macrophage and ex vivo human whole-blood models. J Periodont Res 2008;43:400-407
17. Hamalainen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E: Anti-inflamatory effects of flavonoids: Genistein, kaempferol, quercetin and daidzein inhibit STAT-1 and NF-kB activations, whereas flavone, isorhamnetin, naringenin and pelargonidin inhibit only NF-kB activation along their inhibitory effect of iNOS expression and NO production in activated macrophages. Mediat Inflamm 2007;2007:45673
18. Denny BJ, West PWJ, Mathew TC: Antagonistic interactions between the flavonoids hesperetin and naringenin and b-lactam antibiotics against Staphylococcus aureus. Br J Biomed Sci 2008;65:145-147
19. Goldwasser J, Cohen PY, Lin W, Kitsberg D, Balaguer P, Polyak SJ, Chung RT, Yarmush ML, Nahmias Y: Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism. J Hepatol 2011;55:963-971
20. Nahmias Y, Goldwasser J, Casali M, van Poll D, Wakita T, Chung RT, Yarmush ML: Apolipoprotein B-dependent Hepatitits C virus secretion is inhibited by the grapefruit flavonoid naringenin. Hepatology 2008;47:1437-1445. (Pubitemid 351702727)
21. Ortiz-Andrade RR, Sanchez-Salgado JC, Navarrete-Vasquez G, Webster SP, Binnie M, Garcia-Jimenez S, Leon-Rivera I, Igarroa- Vasquez PC, Villalobos-Molina R, Estrada-Soto S: Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation. Diabetes Obes Metab 2008;10:1097-1104
22. Han X, Pan J, Ren D, Cheng Y, Fan P, Lou H: Naringenin-7-0- glucoside protects against doxorubicin-induced toxicity in H9c22 cardiomyocytes by induction of endogenous antioxidant enzymes. Food Chem Toxicol 2008;46:3140-3146
23. Heo HJ, Kim DO, Shin SC, Kim MJ, Kim BG, Shin DH: Effect of antioxidant flavonone, naringenin, from Citrus junos on neuroprotection. J Agric Food Chem 2004;52:1520-1525
24. Singh D, Chander V, Chopra K: Protective effects of naringin, a bioflavonoid on glycerol-induced acute renal failure in rat kidney. Toxicology 2004;201:143-151. (Pubitemid 39023942)
25. Renugadevi J, Prabu SM: Naringenin protects against cadmiuminduced oxidative renal dysfunction in rats. Toxicology 2009;256:128-134
26. Hsiu SL, Huang TY, Hou YC, Chin DH, Chao DP: Comparison of metabolic pharmacokinetics of naringenin and naringenin in rabbits. Life Sci 2002;70:1481-1489
27. Yen FL, Wu TH, Lin LT, Cham TM, Lin CC: Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-Administered rats with CCl4-induced acute liver failure. Pharm Res 2009;26: 893-902
28. Shulman M, Cohen M, Soto-Gutierrez A, Yagi H, Wang H, Goldwasser J, Lee-Parsons CW, Benny-Ratsaby O, Yarmush ML, Nahmias Y: Enhancement of Naringenin Bioavailability by Complexation with Hydroxypropyl-b-Cyclodextrin. PLoS One 2011;6:e18033
29. Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK: Enhanced therapeutic potential of naringenin-phospholipid complex in rats. J Pharm Parmacol 2008;58:1227-1233. (Pubitemid 44329104)
30. Hadaruga DI, Hadaruga NG, Bandur G, Isengard HD: Water content of flavonoid/cyclodextrin nanoparticles: Relationship with the structural descriptors of biologically active compounds. Food Chem 2012;132:1651-1659
31. Hadaruga DI, Hadaruga NG, Miclea LM, Vlaia L, Mircioiu C: Bioactive compounds (hepatoprotective or anti-inflammatory xenobiotics)/cyclodextrin nanoparticles: A comparative study. J Agroalimentary Processes Technol 2009;15:478-483
32. Hadäruga DI, Hadaruga NG, Hermenean A, Rivis A, Paslaru V, Codina G: Bionanomaterials: Thermal stability of the oleic acid/aand b-cyclodextrin complexes. Rev Roum Chim 2008;59:994-998
33. Hadaruga NG, Hadaruga DI, Paunescu V, Tatu C, Ordodi VL, Bandur G, Lupea AX: Bioactive nanoparticles (6). Thermal stability of linoleic acid/a- And b-Cyclodextrin complexes. Food Chem 2006;99:500-508
34. Europe Co: Appendix A of the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes (ETS No. 123). Cons 123, 3rd edition, 2006
35. Aebi H: Catalase. In: Methods of Enzymatic Analysis (Bergmeyer HU, ed.). Academic Press, New York, NY, 1974, pp. 673-677
36. Paoletti F, Mocali A: Determination of superoxide dismutase activity by purely chemical system based on NADP(H) oxidation. Methods Enzymol 1990;186:209-221
37. Beutler E: Red cell metabolism. In: A Manual of Biochemical Methods (Beutler E, ed.). Grune and Stratton, Orlando, FL, 1984, pp. 68-73
38. Del Rio D, Pellegrini N, Colombi B, Bianchi M, Serafini M, Torta F, Tegoni F, Musci M, Brighenti F: Rapid fluorimetric method to detect total plasma malondialdehyde with mild derivatization conditions. Clin Chem 2003;49:690-692. (Pubitemid 36379547)
39. Lowry OH, Rosebrough NJ Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275
40. Clawson GA: Mechanism of carbon tetrachloride hepatotoxicity. Path Immunopathol Res 1989;8:104-112
41. Weber LW, Boll M, Stampfl A: Hepatotoxicity and mechanism of action of haloalkanes: Carbon tetrachloride as a toxicological model. Crit Rev Toxicol 2003;33:105-136
42. Bolarin DM: Serum bile acid in the evaluation of colchicines treatment of carbon tetrachloride-induced liver injury. Exp Mol Pathol 1984;41:384-389. (Pubitemid 15197470)
43. Chetia P, Bala A, Khandelwal B, Haldar PK: Comparative in vitro free radical scavenging property of b-carotene and naringenin with respect to vitamin C and N-Acetyl Cysteine. Pharmacologia 2012;3:724-728
44. Moskaug JO, Carlsen H, Myhrstad MC, Blomhoff R: Polyphenols and glutathione synthesis regulation. Am J Clin Nutr 2005;81:277S-283S.
45. Townsend DM, Tew KD, Tapiero H: The importance of glutathione in human disease. Biomed Pharmacother 2003;57:145-155
46. Yuan LP, Chen FH, Ling L, Bo H, Chen ZW, Li F, Zhong MM, Xia LJ: Protective effects of total flavonoids of Bidens bipinnata L. against carbon tetrachloride induced liver fibrosis in rats. J Pharm Pharmacol 2008;60:1393-1402
47. de Oliveira e Silva AM, Vidal-Novoa A, Batista-Gonzáles AE, Pinto JR, Portari Mancini DA, Reina-Urquijo W, Marccini-Filho J: In vivo and in vitro antioxidant activity and hepatoprotective properties of polyphenols from Halimeda opuntia (Linnaeus) Redox Rep 2012;17:47-53
48. Ying CJ, Sun XF, Zhang SL, Zhang XP, Mao LM, Zuo XZ, Yao P: ROS-related enzyme expressions in endothelial cells regulated by tea polyphenols. Biomed Environ Sci 2004;17:33-39. (Pubitemid 38638968)
49. Andrade Belo MA, Soares VE, Souza LM, Rosa Sobreira MF, Silveira Cassol DM, Barioni Toma S: Hepatoprotective treatment attenuates oxidative damages induced by carbon tetrachloride in rats. Exp Toxicol Pathol 2012;64:155-165
50. Hermenean A, Popescu C, Ardelean A, Stan M, Hadaruga N, Mihali CV, Costache M, Dinischiotu A: Hepatoprotective effect of Berberis vulgaris L. extract/beta-cyclodextrin on carbon tetrachloride- induced acute toxicity in mice. Int J Mol Sci 2012;13: 9014-9934
51. Tasci I, Mas N, Mas MR, Tuncer M, Comert B: Ultrastructural changes in hepatocytes after taurine treatment in CCl4 induced liver injury. World J Gastroenterol 2008;14:4897-4902
52. Song IM, Lee YM, Chung SJ, Shim CK: Multiple alterations of canalicular membrane transport activities in rats with CCl4-induced hepatic injury. Drug Metab Dispos 2003;31:482-490.